Chinese insurers and their bank partners have halted sales of popular high-yielding investment products in recent days under pressure from regulators, signalling that the explosive growth in premiums that fuelled the industry’s aggressive acquisition spree in recent years is set to slow.
迫於監管壓力，中國保險公司及其銀行合作伙伴近日已停售頗受歡迎的高收益投資產品，這表明推動最近幾年中國保險業激進收購浪潮的保費收入的爆炸性成長將放緩。
您已閱讀8%（362字），剩餘92%（3984字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。